Marker Therapeutics, Inc. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Marker Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2024.
  • Marker Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$2.4M, a 25% increase year-over-year.
  • Marker Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$10.2M, a 3.32% increase year-over-year.
  • Marker Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$14.6M, a 26.3% increase from 2022.
  • Marker Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$19.8M, a 49.9% increase from 2021.
  • Marker Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$39.5M, a 36.7% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$10.2M -$2.4M +$800K +25% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$11M -$2.31M +$1.83M +44.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$12.8M -$2.55M +$1.76M +40.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$14.6M -$2.94M -$4.04M -367% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-26
Q3 2023 -$10.5M -$3.2M +$2.63M +45.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$13.2M -$4.13M +$1.13M +21.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$14.3M -$4.31M +$5.49M +56% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$19.8M $1.1M +$10.9M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-26
Q3 2022 -$30.7M -$5.83M +$4.2M +41.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$34.9M -$5.27M +$5.64M +51.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$40.5M -$9.79M -$1.01M -11.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$39.5M -$9.76M -$1.26M -14.8% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-22
Q3 2021 -$38.2M -$10M -$2.65M -35.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$35.6M -$10.9M -$4.55M -71.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$31M -$8.78M -$2.14M -32.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 -$28.9M -$8.51M -$3.15M -58.7% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-17
Q3 2020 -$25.7M -$7.38M -$1.72M -30.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$24M -$6.36M -$484K -8.24% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 -$23.5M -$6.64M -$1.01M -17.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 -$22.5M -$5.36M +$131M +96.1% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-09
Q3 2019 -$153M -$5.65M -$1.23M -27.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$152M -$5.87M -$1.2M -25.7% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$151M -$5.64M -$2.44M -76.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$148M -$136M -$133M -4969% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-12
Q3 2018 -$15M -$4.43M -$439K -11% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$14.5M -$4.67M -$2.28M -95.3% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 -$12.3M -$3.2M -$781K -32.3% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 -$11.5M -$2.68M -$1.09M -68.4% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-15
Q3 2017 -$10.4M -$3.99M -$1.27M -46.6% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 -$9.12M -$2.39M +$32.3K +1.33% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$9.16M -$2.42M -$663K -37.8% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$8.49M -$1.59M +$663K +29.4% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-23
Q3 2016 -$9.16M -$2.72M -$984K -56.6% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$8.17M -$2.43M -$1.29M -113% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 -$6.88M -$1.75M -$726K -70.6% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-05
Q4 2015 -$6.16M -$2.25M Oct 1, 2015 Dec 31, 2015 10-K 2017-03-14
Q3 2015 -$1.74M Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-04
Q2 2015 -$1.14M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 -$1.03M Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
Q4 2013 -$2.66M -$561K Oct 1, 2013 Dec 31, 2013 10-K 2015-04-15
Q3 2013 -$313K +$483K +60.7% Jul 1, 2013 Sep 30, 2013 10-Q 2013-11-19
Q2 2013 -$675K +$2.46M +78.5% Apr 1, 2013 Jun 30, 2013 10-Q 2013-08-19
Q1 2013 -$1.12M -$443K -66% Jan 1, 2013 Mar 31, 2013 10-Q/A 2013-08-19
Q3 2012 -$5.22M -$797K +$108K +12% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-19
Q2 2012 -$5.32M -$3.14M -$2.44M -347% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-19
Q1 2012 -$2.89M -$672K +$429K +38.9% Jan 1, 2012 Mar 31, 2012 10-Q/A 2013-08-19
Q4 2011 -$3.32M -$609K Oct 1, 2011 Dec 31, 2011 10-K 2012-04-16
Q3 2011 -$905K +$329K +26.7% Jul 1, 2011 Sep 30, 2011 10-Q 2011-11-21
Q2 2011 -$701K +$581K +45.3% Apr 1, 2011 Jun 30, 2011 10-Q/A 2012-09-12
Q1 2011 -$1.1M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-21
Q3 2010 -$1.23M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-21
Q2 2010 -$1.28M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.